Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 23, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Epilepsy

Interventions

DRUG

AMSCs

A single dose of 5x10\^6 AMSCs will be resuspended in 1ml of LRS and infused via intraparenchymal at the time of DBS surgery

Trial Locations (1)

RECRUITING

Mayo Clinic, Jacksonville

All Listed Sponsors

lead

Sanjeet S. Grewal

OTHER